Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | mitogen-activated protein kinase 14 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Trypanosoma brucei | mitogen-activated protein kinase 5 | mitogen-activated protein kinase 14 | 360 aa | 336 aa | 33.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1448 | 1 | 1 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.1448 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0865 | 0.4901 | 0.4901 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0782 | 0.4171 | 0.4171 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0486 | 0.1579 | 0.1579 |
Trypanosoma brucei | phosphatidylinositol 3-kinase tor, putative | 0.0685 | 0.3322 | 0.207 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0389 | 0.0729 | 0.0729 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1152 | 0.7408 | 0.7408 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1077 | 0.6753 | 0.6753 |
Leishmania major | target of rapamycin (TOR) kinase 1, putative | 0.1448 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0865 | 0.4901 | 0.4901 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.1077 | 0.6753 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0486 | 0.1579 | 0.1579 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.1448 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1448 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1077 | 0.6753 | 0.6753 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0781 | 0.4161 | 0.4161 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1077 | 0.6753 | 0.6753 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1077 | 0.6753 | 0.6753 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.1448 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.094 | 0.5555 | 0.5555 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.1448 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0486 | 0.1579 | 0.1579 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0971 | 0.5829 | 0.5829 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0782 | 0.4171 | 0.4171 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.1448 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1152 | 0.7408 | 0.7408 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0865 | 0.4901 | 0.4901 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1077 | 0.6753 | 0.6753 |
Trypanosoma brucei | FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative | 0.0601 | 0.2592 | 0.1204 |
Giardia lamblia | GTOR | 0.1448 | 1 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0486 | 0.1579 | 0.1579 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1152 | 0.7408 | 0.7408 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1152 | 0.7408 | 0.7408 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0782 | 0.4171 | 0.4171 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0857 | 0.4826 | 0.4826 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0781 | 0.4161 | 0.4161 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.1448 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0781 | 0.4161 | 0.4161 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1152 | 0.7408 | 0.7408 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0857 | 0.4826 | 0.4826 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0782 | 0.4171 | 0.4171 |
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.1153 | 0.7418 | 0.6934 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1077 | 0.6753 | 0.6753 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0486 | 0.1579 | 0.1579 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1236 | 0.8147 | 0.8147 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1077 | 0.6753 | 0.6753 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.1448 | 1 | 1 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.1448 | 1 | 0.5 |
Leishmania major | target of rapamycin kinase (TOR) kinase 3 | 0.1153 | 0.7418 | 0.6934 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.1153 | 0.7418 | 0.6934 |
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.1448 | 1 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0486 | 0.1579 | 0.1579 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1448 | 1 | 1 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.1448 | 1 | 1 |
Leishmania major | target of rapamycin (TOR) kinase 2, putative | 0.1448 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Kd (binding) | = 1.2 nM | Binding affinity for Mitogen-activated protein kinase p38 alpha | ChEMBL. | 12941343 |
Kd (binding) | = 1.2 nM | Binding affinity for Mitogen-activated protein kinase p38 alpha | ChEMBL. | 12941343 |
Koff (binding) | = 0.000023 s-1 | Rate of dissociation from Mitogen-activated protein kinase p38 alpha | ChEMBL. | 12941343 |
Kon (binding) | = 18700 M-1 s-1 | Rate of association to Mitogen-activated protein kinase p38 alpha | ChEMBL. | 12941343 |
k_off (binding) | = 0.000023 s-1 | Rate of dissociation from Mitogen-activated protein kinase p38 alpha | ChEMBL. | 12941343 |
k_on (binding) | = 18700 M-1 s-1 | Rate of association to Mitogen-activated protein kinase p38 alpha | ChEMBL. | 12941343 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.